MARATTO

article · Budapest International Research in Exact Sciences (BirEx Journal)

Antisickling and Antibacterial Activities of Anthocleista schweinfurthii Gilg. (Gentianaceae) from Non-human Primates Pharmacopoeia in Democratic Republic of the Congo

20193 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

The aim of the present study was to evaluate the Chemical composition and bioactivity of Anthocleista schweinfurthii Gilg (Gentianaceae) fruits, leaves, root bark and stem bark extracts against Sickle cell disease (SCD) and associated bacteria. The antisickling and antibacterial activities were carried out using Emmel and micro-dilution methods respectively. The results revealed that the fruits, leaves, root bark and stem bark extracts of A. schweinfurthii contains various secondary metabolites such as the alkaloids, saponins, total polyphenols, flavonoids, tannins, anthocyanis, leuco-anthocyanins and quinones. The ethyl acetate and methanol extracts displayed antisickling activity. While, the antibacterial activity of different plant extracts tested was weak toward tested bacterial strains (CMI ≥125μg/mL). The antibacterial activity can be improved by bio-guided fractionation of the n-hexane, ethyl acetate or methanol soluble fraction. This study provides for the first time a scientific basis for the in vitro antisickling activity of A. schweinfurthii.

Research topics

  • Ethnobotanical and Medicinal Plants Studies
  • Phytochemistry and Biological Activities
  • Phytochemistry and biological activities of Ficus species

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.33258/birex.v1i3.345

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.